cancerpatients
-
Advertising Policy
GUcancers accepts advertising on the GUcancers Network from third parties (“Advertisers”), which may include third party banners, badges, contextual advertising…
Read More » -
Editorial policy
GUcancers.com and its affiliates (“GUCancers” or “Biomedz” or “we”), which operate www.GUcancers.com (“GUCancers”), are committed to providing GUCancers users with…
Read More » -
ASCO
ASCO21 Meeting Summary – Kidney Cancer
Practice Changing Results in RCC come from ASCO 2021 Ochsner Precision Cancer Therapies Program and Ochsner Cancer Institute, Benson Cancer…
Read More » -
ASCO
ASCO21 Sessions: RECOMMENDED ABSTRACTS in Renal Cancer
These recommended abstracts have been selected by Robert A. Figlin, MD, Editor-in- Chief of the Kidney Cancer Journal. The chosen abstracts provided…
Read More » -
Cancer
MEDICAL INTELLIGENCE – Kidney Cancer
Newsworthy, late-breaking kidney cancer information from Web-based sources, professional societies, and government agencies FDA Approves Tivozanib as First Therapy for…
Read More » -
ASCO
ASCO21 Kidney Cancer Roundup
Robert A Figlin, MD Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Health System, Los Angeles, CA The COVID-19 pandemic has…
Read More » -
Cancer
Roundtable Discussion – Cancer and COVID-19
Robert J. Motzer, MD¹, Eric A. Jonasch, MD2,Bradley A. McGregor, MD3, Robert A. Figlin, MD, FACP4 1 Memorial Sloan Kettering…
Read More » -
Cancer
Occult Brain Mets Detected in Patients With Advanced Renal Cancer
MONDAY, May 2, 2021 — Recent study by researchers of Memorial Sloan Kettering Cancer Center highlights that 4% to 5%…
Read More » -
Cancer
Editor’s Memo
Robert A. Figlin MD Novel Drug Combinations Gain Traction Across Therapeutic Landscape More than a year since the COVID-19 crisis…
Read More » -
Cancer
Black people and Native Americans are under-represented in Cancer Drug trials of new drugs
Black people and Native Americans are under-represented in clinical trials of new drugs, even when the treatment is aimed at…
Read More »
